Iceland· IS-EU/1/02/223/001-003
Evra
A norelgestromin and ethinylestradiol product containing ethinylestradiolum inn,norelgestromin, registered in Iceland by Gedeon Richter Plc.*. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Norelgestromin and ethinylestradiol is registered in 11 of 19 countries.
Countries holding a registration under ATC G03AA13 (norelgestromin and ethinylestradiol), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Norelgestromin and ethinylestradiol · ATC G03AA13
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Ethinylestradiolum INN,Norelgestromin
- Manufacturer
- Gedeon Richter Plc.*
- Country
- Iceland (IS)
- ATC code
- G03AA13
- ATC class
- Norelgestromin and ethinylestradiol
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean0129219 stk x1 pakkiISK 6491
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
33 interactions on record for norelgestromin and ethinylestradiol.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Norelgestromin and ethinylestradiol · interactions on record
33 records
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Norelgestromin and ethinylestradiol in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainEVRA 203 MICROGRAMOS/24 hORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICOJanssen-Cilag International N.V
- United StatesGwyn LoViatris Specialty LLC
- CzechiaEVRAGedeon Richter Plc., Budapešť
- United KingdomEvra transdermal patchesDowelhurst Ltd
- IrelandEvraGedeon Richter Plc
- SwitzerlandEvra, transdermales PatchGedeon Richter (Schweiz) AG
- FinlandEvraGedeon Richter Plc
- CanadaEVRASEARCHLIGHT PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Evra
- Norway · Evra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f56a5bad-d8c7-4c42-b719-a084e94c93b7 GET /v1/drugs/f56a5bad-d8c7-4c42-b719-a084e94c93b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Forðaplástur",
"source": "lyfjastofnun",
"atc_raw": "G03AA13",
"marketed": true,
"strength": "203 míkróg/24 klst +33,9 míkróg/24 klst.",
"ma_number": "EU/1/02/223/001-003",
"substance": "Ethinylestradiolum INN,Norelgestromin",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "37551"
}See everything about norelgestromin and ethinylestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.